Image (Xocova 01)
Xocova Tablet
Product Images NDC 59630-711
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Xocova (NDC 59630-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Shionogi Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Xocova 02)
Figure 1 (Xocova 03)
The text mentions a chart showing the proportion of an event over time, specifically for different groups labeled as "Placebo" and "Ensitrelvir." The data is displayed for multiple days from the start of treatment, indicating the percentage of the event occurring in each group on those days.*
Image (Xocova 04)
Image (Xocova 05)
This is a prescription medication labeled as "Xocova" with the active ingredient "ensitrelvir." Each tablet contains 125 mg of the active ingredient. The dosing instructions indicate taking 3 tablets as a single dose on Day 1, followed by 1 tablet once daily on Days 2 through 5, making a total of 7 tablets for the complete course. It is for oral use only.*
Image (Xocova 06)
This text appears to be a medication label for a tablet containing 126 mg per tablet. The instructions mention a single dose on Day 1, and possibly consistent dosing on subsequent days. It is recommended to take about the same time each day and the label mentions administration on Days 2 and through. The lot number provided is 0000000x.*
Image (Xocova 07)
This text provides information about medication in tablet form containing 125 mg per tablet. The instructions suggest taking 3 tablets as a single dose on Day 1, then 1 tablet daily on Days 2 through 5, preferably at the same time each day. The product is manufactured by a company identified as "Fimam" in the US and is associated with Lot 0000000x.*
Principal Display Panel-125 mg Tablet Blister Carton (Xocova 08)
This is a prescription information sheet for Xocova tablets, containing 125 mg per tablet. The recommended dosage is to take three tablets on Day 1 as a single dose, followed by one tablet once daily from Days 2 to 5. This medication is for oral use and should only be used as prescribed by a healthcare professional.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
